Company profile
Vertex Pharmaceuticals Inc / Ma Insider Trading
VRTXEvery SEC Form 4 insider trading filing for Vertex Pharmaceuticals Inc / Ma (VRTX) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0000875320
- Filings
- 348
- Insiders
- 28
- Last filing
- 2026-09-08
Activity summary
Recent insider activity is bullish. Over the last 30 days, 2 insiders purchased shares. Buying was led by Grunsven Jasper van.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Vertex Pharmaceuticals Inc / Ma insiders were net sellers in every quarter shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $127.3M.
90 day insight
Over the last 90 days, Vertex Pharmaceuticals Inc / Ma insiders bought $62K across 6 transactions with no open-market sales.
- Most active insider: Ourania Tatsis with 2 transactions totaling $787K.
- Largest single sale: $800K by Duncan McKechnie on Jul 2, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Grunsven Jasper van | VRTX | Award | 8,682 | — | — |
| Aug 28, 2026 | Kristen Ambrose | VRTX | Award | 5,000 | — | — |
| Aug 27, 2026 | Bruce I Sachs | VRTX | Gift | 6,000 | — | — |
| Jul 21, 2026 | Amit Sachdev | VRTX | Award | 8,251 | — | — |
| Jul 21, 2026 | Ourania Tatsis | VRTX | Award | 8,251 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=VRTX" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Vertex Pharmaceuticals Inc / Ma as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →